Jon Cuthbert

Biogen (NASDAQ:BIIB) and Eisai have cleared a significant regulatory hurdle as the U.S. Food and Drug Administration (FDA) accepted their supplemental Biologics License Application for a subcutaneous version of the Alzheimer’s treatment Leqembi.

Coinbase says Davos discussions point to rising momentum for tokenisation and clearer US crypto rules.

A US SEC filing reveals a proposed S&P crypto ETF would be overwhelmingly driven by bitcoin, ethereum and XRP performance.

Gold hit a record above $5,000 as bitcoin fell sharply, highlighting a growing divergence driven by macro and geopolitical risks.

Crypto startup Entropy will wind down operations and refund investors after years of pivots and scaling challenges.

Michael Saylor’s warning on bitcoin protocol changes has sparked renewed debate over innovation, security, and quantum threats.

Ledger is preparing for a US IPO as growing demand for secure crypto hardware wallets fuels investor interest.

Prediction markets signal short-term caution for bitcoin below $87,000, even as long-term bets remain firmly bullish.

Secret tapes suggest Trump tariff plans may fuel inflation and volatility, raising fresh risks for bitcoin and the wider crypto market.

Bill Miller IV said Bitcoin (CRYPTO:BTC) would trade near $1.7 million per coin if markets fully recognised it as the digital equivalent of gold.